# DESCRIPTION

## TECHNICAL FIELD

- introduce rheumatoid arthritis and its evaluation methods

## BACKGROUND ART

- describe rheumatoid arthritis and its effects
- explain limitations of current treatment methods
- discuss importance of early detection and treatment
- describe difficulties in diagnosing rheumatoid arthritis
- introduce various evaluation methods for disease activity
- discuss limitations of DAS28 method
- describe proposed rheumatoid arthritis markers
- discuss limitations of current markers
- introduce glycan analysis for diagnosis
- discuss limitations of glycan analysis
- describe need for a new, simple, and accurate evaluation method

## SUMMARY OF THE INVENTION

### Problems to be Solved by the Invention

- state objectives

### Mean for Solving the Problems

- focus on MMP-3 in serum
- find increased secretion of MMP-3 in rheumatoid arthritis
- observe changed glycan profile of MMP-3
- develop antibody-overlay-lectin array method
- apply method to patient serum
- select lectin recognizing glycan specific to MMP-3
- identify O-linked glycan of MMP-3
- find correlation between Jacalin signal and MMP-3 amount
- investigate clinical usefulness of difference
- examine ABA/Jacalin value
- verify correlation with disease activity
- provide glycan biomarker of inverse correlation
- measure value obtained by correcting Jacalin signals
- evaluate disease activity of rheumatoid arthritis
- provide kit for evaluation of disease activity
- include anti-MMP-3 antibody and lectins in kit
- prepare lectin array
- review results of lectin array profiling
- select LEL and STL lectins
- examine reactivity of MMP-3 with LEL and STL lectins
- confirm LEL or STL lectin-reactive glycan as biomarker
- measure ratio of LEL lectin signals to Jacalin or ACG signals
- discriminate polymyalgia rheumatica and relapsing polychondritis
- accurately diagnose rheumatoid arthritis
- define biomarkers for rheumatoid arthritis
- describe MMP-3 for determining disease activity
- outline use of MMP-3 O-linked glycan for assessing disease activity
- introduce reagents for assessing disease activity
- describe kit for assessing disease activity
- define glycan epitope for diagnosis of polymyalgia rheumatica and relapsing polychondritis
- outline reagent for diagnosing polymyalgia rheumatica and relapsing polychondritis
- describe method for diagnosing polymyalgia rheumatica and relapsing polychondritis
- outline method for determining whether a subject suffers from polymyalgia rheumatica and relapsing polychondritis
- describe method for diagnosing rheumatoid arthritis
- outline kits for diagnosis of polymyalgia rheumatica, relapsing polychondritis, and rheumatoid arthritis

### Effects of the Invention

- summarize benefits in medical practice
- describe kit for disease activity determination
- outline diagnosis methods for rheumatic diseases

## MODES FOR CARRYING OUT THE INVENTION

### 1. Glycan Biomarker for Rheumatoid Arthritis in the Present Invention

- define MMP-3 glycan biomarker
- motivate MMP-3 in rheumatoid arthritis diagnosis
- describe MMP-3 production in synovial cells
- discuss limitations of MMP-3 level in serum
- introduce Jacalin-binding O-linked glycan of MMP-3
- describe Jacalin lectin properties
- discuss other lectins used in the invention
- define glycan epitope to become glycan biomarker
- describe O-linked glycan structure of MMP-3
- discuss sialic acid modification of O-linked glycan
- conclude glycan epitope as disease activity biomarker

### 2. Method for Determining Disease Activity of Rheumatoid Arthritis of the Present Invention

- define biomarker for rheumatoid arthritis
- describe glycan epitope structure
- explain detection and quantification method
- introduce reagents for disease activity determination
- describe MMP-3 as a marker for disease activity
- explain analysis method for MMP-3
- define glycosylation discrimination index
- describe method for determining disease activity
- introduce detection and quantification by lectin array or sandwich ELISA method
- describe lectin array analysis method
- explain concentration of MMP-3-containing fraction
- describe purification method
- introduce labeling substances
- describe lectin array preparation
- describe application to lectin array and washing
- describe detection method
- describe evanescent wave excitation fluorescence detection method
- describe binding ability between lectin and glycan
- describe cluster effect
- describe antibody-overlay-lectin array method
- describe detection method using lectin array
- describe sandwich method
- describe immobilization of capture agent
- describe labeling of detection agent
- describe detection using enzyme as labeling substance
- describe measurement of signals
- describe sandwich ELISA using anti-MMP-3 antibody
- describe detection and discrimination method of rheumatoid arthritis activity marker
- describe evaluation method without using standard substance

### 3. Kit for Determination of Disease Activity of Rheumatoid Arthritis

- describe kit composition
- outline kit usage

### 4. A Diagnosing Method for Accurately Discriminating Similar Rheumatic Diseases, and Diagnostic Kit for the Method

- motivate lectin-based diagnosis
- describe lectin array method
- outline sandwich method
- summarize diagnostic method

## EXAMPLES

- introduce examples

### (Example 1) Measurement of the Abundance of MMP-3 in Serum Sample

- preclear process
- immunoprecipitation process
- elution process
- biotinylated antibody removal process
- results

### (Example 2) Glycan Profiling by Antibody-Overlay-Lectin Array

- prepare MMP-3-IP samples
- perform lectin array analysis
- analyze glycan structure information
- examine correlation between lectin signals and MMP-3 level

### (Example 3) Comparative Analysis Between Acquired Data and Clinical Parameters

- examine correlation between lectin signals and clinical parameters
- analyze correlation between ABA/Jacalin value and disease activity

### (Example 4) Influence of Sialidase Digestion on Glycan Profile

- enrich MMP-3 in serum
- perform sialidase digestion
- perform glycan profiling by antibody-overlay-lectin array
- analyze results

### (Example 5) Glycan Profiling of MMP-3 in Synovial Fluid

- enrich MMP-3 in synovial fluid
- perform glycan profiling by antibody-overlay-lectin array

### (Example 6) Ability to Discrimination of MMP-3 Positive Diseases

- compare reactivity with MMP-3 O-linked glycan
- analyze glycan structure information for each disease
- observe disease-specific dissociation between Jacalin and MMP-3 level
- calculate ACG/Jacalin values for RA activity
- compare reactivity with lectin recognizing polylactosamine structure
- analyze signals of LEL and STL lectin-reactive glycans for disease discrimination
- create indexes for RA detection using ratio of lectin signals

